Contribute Try STAT+ Today

Wastewater treatment plants that accept discharges from pharmaceutical manufacturing facilities send “substantially” higher concentrations of medicines into rivers and streams than treatment plants that do not take these discharges, according to the first study to examine the issue across the U.S.

In reaching their conclusion, the study authors compared effluent — which is wastewater that is sent into rivers and other natural bodies of water — from 13 treatment plants that took pharmaceutical discharges and six plants that did not. They examined plants scattered among rural and urban locations around the country in order to compare plant sizes, varying climates, and technology used for treating wastewater.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.